EW - Edwards Lifesciences Corporation

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 538.97B
Enterprise Value 339.5B
Trailing P/E 52.12
Forward P/E 132.00
PEG Ratio (5 yr expected) 13.09
Price/Sales (ttm)10.20
Price/Book (mrq)11.34
Enterprise Value/Revenue 310.34
Enterprise Value/EBITDA 632.95

Trading Information

Stock Price History

Beta (3Y Monthly) 0.95
52-Week Change 327.42%
S&P500 52-Week Change 37.06%
52 Week High 3197.86
52 Week Low 3134.53
50-Day Moving Average 3184.45
200-Day Moving Average 3177.23

Share Statistics

Avg Vol (3 month) 31.33M
Avg Vol (10 day) 31.02M
Shares Outstanding 5208.11M
Float 207.13M
% Held by Insiders 13.94%
% Held by Institutions 10.00%
Shares Short (Jun 28, 2019) 42.75M
Short Ratio (Jun 28, 2019) 41.81
Short % of Float (Jun 28, 2019) 41.48%
Short % of Shares Outstanding (Jun 28, 2019) 41.32%
Shares Short (prior month May 31, 2019) 42.28M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3Dec 14, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 20.03%
Operating Margin (ttm)29.31%

Management Effectiveness

Return on Assets (ttm)12.40%
Return on Equity (ttm)22.87%

Income Statement

Revenue (ttm)3.82B
Revenue Per Share (ttm)18.32
Quarterly Revenue Growth (yoy)11.00%
Gross Profit (ttm)2.78B
EBITDA 1.2B
Net Income Avi to Common (ttm)765.3M
Diluted EPS (ttm)3.60
Quarterly Earnings Growth (yoy)20.90%

Balance Sheet

Total Cash (mrq)963M
Total Cash Per Share (mrq)4.62
Total Debt (mrq)666.2M
Total Debt/Equity (mrq)19.32
Current Ratio (mrq)3.66
Book Value Per Share (mrq)16.54

Cash Flow Statement

Operating Cash Flow (ttm)777M
Levered Free Cash Flow (ttm)304.68M